According to a new report by Polaris Market Research, the global preclinical CRO market was valued at USD 6.49 billion in 2025 and is projected to reach USD 13.31 billion by 2034, expanding at a CAGR of 8.30% from 2026 to 2034. Growth is underpinned by rising outsourcing of early-stage drug development, expanding biopharmaceutical R&D budgets, and accelerating demand for...